Shots:

• The US FDA has authorized Quest SARS-CoV-2 rRT-PCR test for use with pooled samples containing up to 4 individual swab specimens collected under observation. The Quest test is the first COVID-19 diagnostic test to be authorized for use with pooled samples
• Quest Diagnostic expects to deploy the technique at its laboratories in Chantilly- VA and Marlborough- Mass.- by the end of next week with additional laboratories to follow
• The company has received the FDA’s EUA for use of self-collection molecular diagnostic kit on the Hologic and Roche’s platforms- expanding use with healthcare provider supervision via telemedicine

  Ref: PRNewswire | Image: Glassdoor